NEO — Neogenomics Balance Sheet

0.000.00%

Last trade - 00:00

HealthcareAdventurousMid CapNeutral

Annual balance sheet for Neogenomics, fiscal year end - December 31st, USD millions except per share, conversion factor applied.

	2021 December 31st	2022 December 31st	2023 December 31st	2024 December 31st	2025 December 31st
Period Length:	—	—	—	—	—
Source:	10-K	10-K	10-K	10-K	10-K
Standards:	USG	USG	USG	USG	USG
Status:	Final	Final	Final	Final	Final
Cash and Equivalents
Short Term Investments
Cash and Short Term Investments	515	438	415	387	160
Net Total Accounts Receivable
Net Total Receivables	114	122	131	151	159
Total Inventory
Prepaid Expenses
Total Other Current Assets
Total Current Assets	682	605	597	596	376
Gross Property, Plant And Equipment
Accumulated Depreciation
Net Property, Plant And Equipment	212	199	184	174	163
Net Goodwill
Net Intangible Assets
Long Term Investments
Long Term Notes Receivable
Other Long Term Assets
Total Assets	1,870	1,740	1,681	1,638	1,360
Accounts Payable
Accrued Expenses
Notes Payable / Short Term Debt
Current Portion of Long Term Debt / Capital Leases
Total Other Current Liabilities
Total Current Liabilities	87.2	89.9	96.3	301	88.3
Long Term Debt
Capital Lease Obligations
Total Long Term Debt
Total Debt
Deferred Income Tax
Total Other Liabilities
Total Liabilities	762	742	740	736	523
Common Stock
Additional Paid In Capital
Retained Earnings (Accumulated Deficit)
Other Equity
Total Equity	1,108	998	942	902	837
Total Liabilities & Shareholders' Equity	1,870	1,740	1,681	1,638	1,360
Total Common Shares Outstanding